Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by wyndeweston Jun 30, 2017 9:41am
235 Views
Post# 26423497

RE:FDA response delays

RE:FDA response delays Agalea, I like your post and am optimistic about the outcome of PLI's BLA submission to the FDA as you articulated.  What does annoy me a is that PL managed to raise $ just in the nick of time... As with the other financings, those newbies who thought they got a bargain are going to find out they could have had it cheaper.  It is a repeating scenario.  I guess I have to be grateful Pierre has the drive and nerves to do so.  We have enough $ (I hope) to get us through a delayed FDA decision. The long term shareholders and those who bought into previous financing are paying a high price for  an opportunity to be part of PLI's success.
Bullboard Posts